426 related articles for article (PubMed ID: 32652238)
21. Chronic pain patients' treatment preferences: a discrete-choice experiment.
Mühlbacher AC; Junker U; Juhnke C; Stemmler E; Kohlmann T; Leverkus F; Nübling M
Eur J Health Econ; 2015 Jul; 16(6):613-28. PubMed ID: 24950770
[TBL] [Abstract][Full Text] [Related]
22. Using a discrete choice experiment to elicit patients' preferences and willingness-to-pay for knee osteoarthritis treatments in Thailand.
Luksameesate P; Tanavalee A; Ngorsuraches S; Taychakhoonavudh S
Sci Rep; 2023 Jul; 13(1):12154. PubMed ID: 37500677
[TBL] [Abstract][Full Text] [Related]
23. A review of pharmacotherapy for chronic low back pain with considerations for sports medicine.
Peniston JH
Phys Sportsmed; 2012 Nov; 40(4):21-32. PubMed ID: 23306412
[TBL] [Abstract][Full Text] [Related]
24. PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.
Poulos C; Kinter E; van Beek J; Christensen K; Posner J
Int J Technol Assess Health Care; 2018 Jan; 34(4):425-433. PubMed ID: 30251947
[TBL] [Abstract][Full Text] [Related]
25. Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment.
Boeri M; Sutphin J; Hauber B; Cappelleri JC; Romero W; Di Bonaventura M
J Dermatolog Treat; 2022 May; 33(3):1449-1458. PubMed ID: 33023361
[TBL] [Abstract][Full Text] [Related]
26. A harm reduction model to assess the impact of new treatments for pain over standard of care among patients with osteoarthritis.
Silverman S; Schepman P; Rice JB; Robinson RL; White AG; Fernan C; Beck CG
J Manag Care Spec Pharm; 2021 Dec; 27(12):1652-1660. PubMed ID: 34818088
[No Abstract] [Full Text] [Related]
27. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
Hodgkins P; Swinburn P; Solomon D; Yen L; Dewilde S; Lloyd A
Patient; 2012; 5(1):33-44. PubMed ID: 22077619
[TBL] [Abstract][Full Text] [Related]
28. An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Stakeholders' Risk Tolerance for Hip Replacement Surgery.
van Dijk JD; Groothuis-Oudshoorn CG; Marshall DA; IJzerman MJ
Value Health; 2016 Jun; 19(4):316-22. PubMed ID: 27325322
[TBL] [Abstract][Full Text] [Related]
29. Short-Acting Opioids Are Associated with Comparable Analgesia to Long-Acting Opioids in Patients with Chronic Osteoarthritis with a Reduced Opioid Equivalence Dosing.
Ghodke A; Barquero S; Chelminski PR; Ives TJ
Pain Med; 2018 Nov; 19(11):2191-2195. PubMed ID: 29121327
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic management of chronic low back pain: synthesis of the evidence.
White AP; Arnold PM; Norvell DC; Ecker E; Fehlings MG
Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S131-43. PubMed ID: 21952185
[TBL] [Abstract][Full Text] [Related]
31. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
Peay HL; Hollin I; Fischer R; Bridges JF
Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
[TBL] [Abstract][Full Text] [Related]
32. Patients' Preferences for Systemic Lupus Erythematosus Treatments-A Discrete Choice Experiment.
Collacott H; Phillips-Beyer A; Krucien N; Flamion B; Marsh K
Patient; 2024 May; 17(3):287-300. PubMed ID: 38270788
[TBL] [Abstract][Full Text] [Related]
33. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
[TBL] [Abstract][Full Text] [Related]
34. The association between depression and type of treatments received for chronic low back pain.
Zubatsky M; Witthaus M; Scherrer JF; Salas J; Gebauer S; Burge S; Schneider FD
Fam Pract; 2020 Jul; 37(3):348-354. PubMed ID: 31746992
[TBL] [Abstract][Full Text] [Related]
35. [Pain medications for acute and chronic low back pain].
Wertli MM; Steurer J
Internist (Berl); 2018 Nov; 59(11):1214-1223. PubMed ID: 30116855
[TBL] [Abstract][Full Text] [Related]
36. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS).
Laba TL; Brien JA; Fransen M; Jan S
BMC Musculoskelet Disord; 2013 May; 14():160. PubMed ID: 23647688
[TBL] [Abstract][Full Text] [Related]
37. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
Fifer S; Rose J; Hamrosi KK; Swain D
BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
[TBL] [Abstract][Full Text] [Related]
38. Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Poulos C; Kinter E; Yang JC; Bridges JF; Posner J; Reder AT
Patient; 2016 Apr; 9(2):171-80. PubMed ID: 26259849
[TBL] [Abstract][Full Text] [Related]
39. Prescription Medication Use Among Community-Based U.S. Adults With Chronic Low Back Pain: A Cross-Sectional Population Based Study.
Shmagel A; Ngo L; Ensrud K; Foley R
J Pain; 2018 Oct; 19(10):1104-1112. PubMed ID: 29678564
[TBL] [Abstract][Full Text] [Related]
40. Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms.
Müller-Schwefe G; Morlion B; Ahlbeck K; Alon E; Coaccioli S; Coluzzi F; Huygen F; Jaksch W; Kalso E; Kocot-Kępska M; Kress HG; Mangas AC; Margarit Ferri C; Mavrocordatos P; Nicolaou A; Hernández CP; Pergolizzi J; Schäfer M; Sichère P
Curr Med Res Opin; 2017 Jul; 33(7):1199-1210. PubMed ID: 28277866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
